- Joined
- Mar 6, 2009
- Messages
- 26,317
Insulin resistance is an ongoing battle for those of us using HGH. Melanotan II has been shown to increase insulin sensitivity and reduce insulin resistance
Central administration of melanocortin agonist increased insulin sensitivity in diet-induced obese rats.
Banno R, et al. FEBS Lett. 2007.
Show full citation
Abstract
In this study, we examined the effects of intracerebroventricular administration of melanotan II (MTII), a melanocortin agonist, on insulin sensitivity in diet-induced obese (DIO) rats. Although MTII treatment significantly decreased food intake and body weight for 10 days, there was no significant difference in body weight between MTII and pair-fed groups. The insulin tolerance test showed that insulin sensitivity was significantly improved in the MTII group compared to the pair-fed group. Furthermore, MTII treatment increased the number of small-sized adipocytes in epididymal white adipose tissues, suggesting that MTII increased insulin sensitivity through action on the white adipose tissues in DIO rats.
Central administration of melanocortin agonist increased insulin sensitivity in diet-induced obese rats.
Banno R, et al. FEBS Lett. 2007.
Show full citation
Abstract
In this study, we examined the effects of intracerebroventricular administration of melanotan II (MTII), a melanocortin agonist, on insulin sensitivity in diet-induced obese (DIO) rats. Although MTII treatment significantly decreased food intake and body weight for 10 days, there was no significant difference in body weight between MTII and pair-fed groups. The insulin tolerance test showed that insulin sensitivity was significantly improved in the MTII group compared to the pair-fed group. Furthermore, MTII treatment increased the number of small-sized adipocytes in epididymal white adipose tissues, suggesting that MTII increased insulin sensitivity through action on the white adipose tissues in DIO rats.